Sunshine Biopharma (SBFM) Other Operating Expenses (2016)

Sunshine Biopharma (SBFM) reported Other Operating Expenses of $25000.0 for Q1 2016.

Sunshine Biopharma (SBFM) Other Operating Expenses (2016) Analysis & Trends

Sunshine Biopharma has reported Other Operating Expenses for 1 years, with the latest figure at $25000.0 in Q1 2016.

For the quarter ending Q1 2016, Other Operating Expenses changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Dec 2016 stood at $25000.0 (changed N/A YoY), and the FY2022 full-year result was -$26.2 million, down 112.9% from the prior year.
Other Operating Expenses for Q1 2016 stood at $25000.0.
The five-year high for Other Operating Expenses was $25000.0 in Q1 2016, with the low at $25000.0 in Q1 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Sunshine Biopharma	11.70 Mn	4.79 Mn	2.18 Mn

Historic Data

Download Data

Date	Value
Mar 31, 2016	25,000.00